FOLH1 and posterior cortical atrophy: 68Ga-labelled prostate-specific membrane antigen positron emission tomography (68Ga-PSMA-PET) is superior to conventional imaging for staging patients with newly diagnosed high-risk PCa [9], providing improved imaging accuracy and sensitivity for men who are candidates for salvage therapy [10, 11].